MDxHealth SA
MDXH
$3.55
$0.082.31%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 28.29% | 33.01% | 45.51% | 65.02% | 89.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.29% | 33.01% | 45.51% | 65.02% | 89.43% |
| Cost of Revenue | 32.91% | 28.60% | 29.27% | 36.45% | 47.26% |
| Gross Profit | 25.52% | 35.89% | 57.29% | 88.42% | 128.57% |
| SG&A Expenses | 8.87% | 11.60% | 12.32% | 22.14% | 34.59% |
| Depreciation & Amortization | -45.41% | 5.34% | 20.48% | 109.32% | 183.53% |
| Other Operating Expenses | -17.35% | -128.56% | -125.07% | -134.13% | 558.57% |
| Total Operating Expenses | 17.44% | 17.91% | 17.47% | 23.67% | 35.74% |
| Operating Income | 10.42% | 13.77% | 27.99% | 29.28% | 21.45% |
| Income Before Tax | 12.58% | 6.91% | 15.48% | 15.97% | 2.15% |
| Income Tax Expenses | 39,100.00% | 169.53% | 200.00% | -- | -- |
| Earnings from Continuing Operations | 11.67% | 6.40% | 15.48% | 15.97% | 2.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.67% | 6.40% | 15.48% | 15.97% | 2.14% |
| EBIT | 10.42% | 13.77% | 27.99% | 29.28% | 21.45% |
| EBITDA | 19.68% | 20.28% | 39.25% | 42.06% | 34.41% |
| EPS Basic | 25.47% | 27.22% | 40.46% | 47.19% | 38.70% |
| Normalized Basic EPS | 35.96% | 65.14% | 78.91% | 78.82% | 78.82% |
| EPS Diluted | 25.47% | 27.22% | 40.46% | 47.19% | 38.70% |
| Normalized Diluted EPS | 35.96% | 65.14% | 78.91% | 78.82% | 78.82% |
| Average Basic Shares Outstanding | 28.65% | 21.32% | 35.16% | 56.16% | 61.37% |
| Average Diluted Shares Outstanding | 28.65% | 21.32% | 35.16% | 56.16% | 61.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |